PLUR vs TECH · rev $1.3M vs P/E 65, rev $1.22B
Pluri Inc. (PLUR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Pluri Inc. (PLUR) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PLUR revenue for 2025-06-30 was $1.3M. Net income was -$23.3M. Revenue was up 309.8% from 2024-06-30 to 2025-06-30. PLUR currently screens at market cap $24.3M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PLUR currently screens at market cap $24.3M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PLUR and TECH stock pages for the full models.
Not investment advice.